Health Catalyst, Inc. (HCAT)

Healthcare · NMS

USD2.12+1.68% today

Fundamentals

Market capUSD159.61M
Revenue growth (YoY)-10.9%
Profit margin-87.7%
Return on equity-103.0%
52-week rangeUSD0.96 to USD4.12

Valuation and ratings

DCF fair valueUSD1.87
Upside to fair value-11.6%
Analyst target (mean)USD1.90
Analyst rangeUSD1.75 to USD2.00
Analysts covering5
Consensus viewbuy
Moat score26/100
Overall rating28/100, Sell

Fair value: USD1.87 (-11.6%), see how we got there

Health Catalyst, Inc. trades at USD2.12, close to the USD1.87 our discounted cash flow model puts on the business. On this measure the market and the model broadly agree, so the interesting question is which of them is wrong.

Our moat model scores it 26 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

HCAT earnings and analyst estimates

Next earnings date6 Aug 2026 (in 9 days)
EPS estimate, next yearUSD0.09
Expected EPS growth+119.7%
Expected revenue growth-6.2%

Recommendation mix, 7 analyst ratings

2 buy5 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Industry: Health Information ServicesEmployees: 1,200HQ: United States

HCAT passes 1 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Common questions

Is Health Catalyst, Inc. (HCAT) undervalued?

Against our discounted cash flow estimate of USD1.87, HCAT at USD2.12 is 12% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.

When does HCAT report earnings next?

Health Catalyst, Inc. is scheduled to report on 6 Aug 2026. Companies move earnings dates, so read it as scheduled rather than certain.

The full research page for HCAT, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.